{[(2R,3R,5R)-5-[4-amino-2-oxo-1,2-dihydro(1,3,5-15N3)-1,3,5-triazin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

• ChemBase编号: 160921
• 分子式: C8H13N4O8P
• 平均质量: 328.15821659
• 单一同位素质量: 328.0352396
• SMILES: [C@H]1(C([C@@H](O[C@@H]1COP(=O)(O)O)[15n]1c(=O)[15n]c([15n]c1)[15NH2])O)O
• Canonical SMILES: OC1[C@@H](O)[C@H](O[C@H]1[15n]1c[15n]c([15n]c1=O)[15NH2])COP(=O)(O)O
• InChI: InChI=1S/C8H13N4O8P/c9-7-10-2-12(8(15)11-7)6-5(14)4(13)3(20-6)1-19-21(16,17)18/h2-6,13-14H,1H2,(H2,9,11,15)(H2,16,17,18)/t3-,4+,5?,6-/m1/s1/i9+1,10+1,11+1,12+1
• InChIKey: WODABQYEPQRZOS-IKCHUYMGSA-N

名称和登记号

名称

• IUPAC标准名: {[(2R,3R,5R)-5-[4-amino-2-oxo-1,2-dihydro(1,3,5-^1^5N₃)-1,3,5-triazin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid
• IUPAC传统名: [(2R,3R,5R)-5-[4-amino-2-oxo(1,3,5-^1^5N₃)-1,3,5-triazin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid
• 别名: 4-Amino-1-(5-O-phosphono-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one-15N4; 4-Amino-1-β-D-ribofuranosyl- s-triazin-2(1H)-one 5'-Phosphate-15N4; 5-Azacytidine-15N4 5'-Monophosphate

登记号

• PubChem SID: 162255056
• PubChem CID: 46780501

理论计算性质

• Acid pKa: 1.2353263
• 质子受体: 10
• 质子供体: 5
• LogD (pH = 5.5): -5.6303024
• LogD (pH = 7.4): -6.7187343
• Log P: -3.344024
• 摩尔折射率: 63.0661 cm^3
• 极化性: 25.322441 Å^3
• 极化表面积: 187.5 Å^2
• 可自由旋转的化学键: 4
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - A796022

A labelled metabolite of 5-Azacytidine.

参考文献

• Lee, T., et al.: Cancer Res., 34, 2482 ( (1974)
• Drake, J.C., et al.: Biochem. Pharmacol., 29, 807 (1974)